Page 30 - ESGO - Vulvar cancer - Complete report_fxd2
P. 30

Table 4. Pooled data on the test accuracy of various techniques for SLN assessment

Authorreference                 Year Blue dye                             99mTc                 Blue dye/99mTc                   Fluorescent materials with
                                                                                                                                 near infrared imaging
Detection rate (patient basis)
   Hassanzade et al.89          2013  78% (95% CI = 66-86)                94% (95% CI = 89-96)  95% (95% CI = 92-97)             85% (95% CI = 68-94)
   Meads et al.90               2014  68.7% (95% CI = 63.1-74.0)                                                                 NA
                                                                          94.0% (95% CI = 90.5-96.4) 97.7% (95% CI = 96.6-98.5)
Detection rate (groin basis)
   Hassanzade et al.89          2013 72% (95% CI = 62-80)                 88% (95% CI = 81-92)  91% (95% CI = 87-94)             85% (95% CI = 64-95)

Sensitivity (patient basis)     2013  89% (95% CI = 65-99)                91% (95% CI = 81-96)  95% (95% CI = 92-98)             NA
   Hassanzade et al.89          2014  94% (95% CI = 69-99)                93% (95% CI = 89-96)  95% (95% CI = 89-97)             NA
   Lawrie et al.91
                                2013  86% (95% CI = 65-97)                95% (95% CI = 87-99)  95% (95% CI = 91-97)             NA
Sensitivity (groin basis)       2014  92% (95% CI = 82-97)                91% (95% CI = 87-94)  94% (95% CI = 88-97)             NA
   Hassanzade et al.89
   Lawrie et al.91

NA: not available

Table 5. Pooled data pulished by Hassanzade et al.89 on the test accuracy of SLN biopsy according to location of the
tumour and inclusion of patients with palpable or suspicious inguinal nodes in the study population)

Test accuracy                         Location of the tumour                        Inclusion of patients with palpable or suspicious
                                                                                    inguinal nodes
                                      Lateral tumours         Midline tumours
                                                                                    Yes No

Detection rate (patient basis)        93% (95% CI = 88-96)    95% (95% CI = 92-97)  92% (95% CI = 86-96   95% (95% CI = 92-97)
Detection rate (groin basis)          93% (95% CI = 88-96)    73% (95% CI = 67-78)  77% (95% CI = 63-88)  82% (95% CI = 76-87)
Sensitivity (patient basis)           92% (95% CI = 79-98)    90% (95% CI = 87-93)  90% (95% CI = 82-96)  92% (95% CI = 88-95)
Sensitivity (groin basis)             91% (95% CI = 75-98)    94% (95% CI = 91-97)  90% (95% CI = 78-97)  92% (95% CI = 89-95)

Table 6. Original studies presenting clinical parameters in patients
treated by SLNB versus ILND

Authorreference                 Year N SLN biopsy ILND                    p-value

Operation time                  2015 128 76.2 min1            103.3 min1  < 0.001
   Brammen et al.171            2008 75 85.5 min              120.7 min   0.002

   Hefler et al.178

Hospital stay                   2015 128 13.3 days            18.1 days   0.006
   Brammen et al.171                                          22.9 days   < 0.001
                                                              13.7 days2  < 0.0001
Hefler et al.178                2008 75 12.6 days

van der Zee et al.145 2008 403 8.4 days2

Inguinal drainage               2015 128 4.1 days             6.9 days    < 0.001
   Brammen et al.171            2008 75 3.3 days              6.9 days    < 0.001

   Hefler et al.178

1 mean value, 2 median value

                                                               VULVAR CANCER - GUIDELINES 
                                                                                     30
   25   26   27   28   29   30   31   32   33   34   35